Citigroup »

Leap Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Leap Therapeutics (CYPH) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Leap Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Leap Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Leap Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2026-03-31 $642 808 0.79

More positions owned by Citigroup

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Bank of America Corporation (BAC)

View all positions for Citigroup

Top funds holding Leap Therapeutics

BlackRock
Vanguard Group
Vanguard Capital Management
Susquehanna International
Geode Capital Management
Vanguard Fiduciary Trust
Citadel Advisors
UBS Group
LPL Financial
State Street Corporation
Jane Street
Group One Trading
Texas Capital Bank Wealth Management Services
Key Client Fiduciary Advisors
Northern Trust

View all funds holding Leap Therapeutics